Forward Pharma A/S

7.32+0.2000+2.81%Vol 2.10K1Y Perf 1.60%
Apr 20th, 2021 16:00 DELAYED
BID7.10 ASK7.32
Open7.18 Previous Close7.12
Pre-Market- After-Market-
 - -%  - -
Target Price
6.00 
Analyst Rating
— 0.00
Potential %
-18.03 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★ —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap49.71M 
Earnings Rating
Neutral
Price Range Ratio 52W %
23.62 
Earnings Date
23rd Apr 2021

Today's Price Range

7.107.36

52W Range

5.6512.72

5 Year PE Ratio Range

-14.001.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
7.49%
1 Month
2.66%
3 Months
11.25%
6 Months
15.64%
1 Year
1.60%
3 Years
-50.67%
5 Years
-73.50%
10 Years
-

TickerPriceChg.Chg.%
FWP7.320.20002.81
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Earnings HistoryEstimateReportedSurprise %
Q04 2016--0.23-
Q03 2016-0.33-0.2330.30
Q02 2016-0.24-0.32-33.33
Q01 2016-0.25-0.27-8.00
Q04 2015--0.25-
Q03 2015-0.29-0.33-13.79
Q02 2015-0.18-0.29-61.11
Q01 2015-0.17-0.18-5.88
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.420.00-
9/2017 QR-0.310.00-
12/2017 FY3.281.16KPositive
12/2018 FY-0.51-64.52Negative
Next Report Date23rd Apr 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.10K
Shares Outstanding6.79M
Trades Count45
Dollar Volume140.69K
Avg. Volume61.68K
Avg. Weekly Volume11.61K
Avg. Monthly Volume31.72K
Avg. Quarterly Volume65.97K

Forward Pharma A/S (NASDAQ: FWP) stock closed at 7.32 per share at the end of the most recent trading day (a 2.81% change compared to the prior day closing price) with a volume of 2.17K shares and market capitalization of 49.71M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 5 people. Forward Pharma A/S CEO is Claus Bo Svendsen.

The one-year performance of Forward Pharma A/S stock is 1.6%, while year-to-date (YTD) performance is 4.13%. FWP stock has a five-year performance of -73.5%. Its 52-week range is between 5.65 and 12.72, which gives FWP stock a 52-week price range ratio of 23.62%

Forward Pharma A/S currently has a PE ratio of -7.20, a price-to-book (PB) ratio of 0.64, a price-to-sale (PS) ratio of -, a price to cashflow ratio of 0.70, a PEG ratio of 2.32, a ROA of -7.83%, a ROC of -4.67% and a ROE of -7.91%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Forward Pharma A/S, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Forward Pharma A/S’s next earnings report date is 23rd Apr 2021.

The consensus rating of Wall Street analysts for Forward Pharma A/S is (0), with a target price of $6, which is -18.03% compared to the current price. The earnings rating for Forward Pharma A/S stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Forward Pharma A/S has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Forward Pharma A/S has a Buy technical analysis rating based on Technical Indicators (ADX : 26.05, ATR14 : 0.52, CCI20 : 111.33, Chaikin Money Flow : 0.01, MACD : -0.10, Money Flow Index : 56.96, ROC : 8.12, RSI : 50.11, STOCH (14,3) : 55.96, STOCH RSI : 1.00, UO : 42.34, Williams %R : -44.04), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Forward Pharma A/S in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Hold
3.00

Forward Pharma A/S

Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis.

CEO: Claus Bo Svendsen

Telephone: +45 33444242

Address: Ostergade 24A, 1st Floor, Copenhagen 1100, , DK

Number of employees: 5

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

52%48%

Bearish Bullish

45%55%

News

Stocktwits